X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs NOVARTIS - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD NOVARTIS ALEMBIC LTD/
NOVARTIS
 
P/E (TTM) x 57.1 300.3 19.0% View Chart
P/BV x 3.2 25.6 12.6% View Chart
Dividend Yield % 0.3 1.4 24.4%  

Financials

 ALEMBIC LTD   NOVARTIS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
NOVARTIS
Mar-17
ALEMBIC LTD/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs53855 6.2%   
Low Rs29666 4.4%   
Sales per share (Unadj.) Rs4.7219.0 2.2%  
Earnings per share (Unadj.) Rs8.819.1 45.9%  
Cash flow per share (Unadj.) Rs9.020.3 44.4%  
Dividends per share (Unadj.) Rs0.1510.00 1.5%  
Dividend yield (eoy) %0.41.3 27.8%  
Book value per share (Unadj.) Rs27.7307.0 9.0%  
Shares outstanding (eoy) m267.0329.96 891.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.73.5 250.6%   
Avg P/E ratio x4.739.8 11.8%  
P/CF ratio (eoy) x4.637.5 12.2%  
Price / Book Value ratio x1.52.5 59.8%  
Dividend payout %1.752.4 3.3%   
Avg Mkt Cap Rs m10,96222,779 48.1%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m2381,393 17.1%   
Avg. sales/employee Rs ThNM9,736.2-  
Avg. wages/employee Rs ThNM2,066.8-  
Avg. net profit/employee Rs ThNM849.0-  
INCOME DATA
Net Sales Rs m1,2606,562 19.2%  
Other income Rs m264702 37.6%   
Total revenues Rs m1,5247,264 21.0%   
Gross profit Rs m83259 32.0%  
Depreciation Rs m6136 171.0%   
Interest Rs m07 4.2%   
Profit before tax Rs m285917 31.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6345 1.8%   
Profit after tax Rs m2,343572 409.4%  
Gross profit margin %6.63.9 166.5%  
Effective tax rate %2.137.6 5.7%   
Net profit margin %185.98.7 2,131.9%  
BALANCE SHEET DATA
Current assets Rs m1,6899,731 17.4%   
Current liabilities Rs m4861,830 26.6%   
Net working cap to sales %95.4120.4 79.3%  
Current ratio x3.55.3 65.3%  
Inventory Days Days21749 445.6%  
Debtors Days Days8125 322.1%  
Net fixed assets Rs m1,62457 2,839.3%   
Share capital Rs m534141 379.6%   
"Free" reserves Rs m5,9609,056 65.8%   
Net worth Rs m7,4049,196 80.5%   
Long term debt Rs m1040-   
Total assets Rs m8,01011,499 69.7%  
Interest coverage x950.7128.4 740.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.20.6 27.6%   
Return on assets %29.35.0 580.5%  
Return on equity %31.66.2 508.6%  
Return on capital %31.310.1 311.2%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m364NA-   
Fx inflow Rs m37129 28.8%   
Fx outflow Rs m3651,734 21.0%   
Net fx Rs m-328-1,605 20.4%   
CASH FLOW
From Operations Rs m346-380 -91.1%  
From Investments Rs m-484,208 -1.1%  
From Financial Activity Rs m-301-3,318 9.1%  
Net Cashflow Rs m-3510 -0.6%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.2 2.0 10.0%  
FIIs % 9.7 1.6 606.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 21.5 121.4%  
Shareholders   54,701 41,647 131.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  SHASUN PHARMA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS